{"prompt": "['PREDM', 'Page 21', 'al.39 and available in Appendix I. Participants will also be asked to bring all', 'dispensed medication to campus at week 12 and 24 visits to perform in person pill-', 'counts and any unused medication will be returned to pharmacy to be logged and', 'discarded. Additionally, we will report on the proportion of days covered (PDC)', 'where PDC= (number of days in period \"covered\"/number of days in period)* 100%', 'where \"covered\" refers to metformin being in the patients possession after a study', 'visit or mail-out refill. Adherence to the digitally-delivered core curriculum will be', 'assessed by completion of lessons on the app-based platform.', 'Safety and Adverse Events: Assessment of side effects and adverse events', 'assessed using the Global Rating of Side Effects Burden (Appendix II), which', 'includes the Common Terminology Criteria for Adverse Events (CTCAE v5.0)', 'grade. The CTCAE grading criteria, published by the National Cancer Institute', '(NCI) is the accepted standard classification and grading scale for adverse events in', 'cancer therapy clinical trials. These criteria will be assessed by phone or in person', 'at weeks 2, 4, 8, 12, 16, 20 and 24. Additionally, study labs at week 12 and 24', 'study visits will assess for any safety concerns (CMP, lactate, cystatin C, complete', 'blood count (CBC)). Pregnancy testing will be performed for female participants at', 'week 12 and 24 study visits and, arranged as needed, based on symptoms and', 'menstrual history.', '4.2.2 Secondary Outcomes of PREDM', 'Glycemia will be measured using FPG and HbA1c. All fasting labs will be', 'performed after a minimum of an 8 hour overnight fast (water is the only liquid that', 'may be consumed during this period). Measures for an individual participant at', 'weeks 12 and 24 will be compared to baseline. If at any study visit a participant', 'meets American Diabetes Association (ADA) criteria for diabetes, 40 FPG is > 126', 'mg/dL or HbA1c is >6.5% and the two tests are discordant (FPG is >126 mg/dL but', 'HbA1c is <6.5% or FPG is <126 mg/dL but HbA1c is 6.5%) then the test which', 'was in the diabetic range will be repeated using a fresh blood sample. If both FPG', 'and HbA1c meet criteria for diabetes, or the two separate tests are concordant (FPG', '>126 mg/dL or HbA1c >6.5% on two occasions), the participant will be recorded as', 'developing diabetes and be notified. They will be referred to their primary care', 'provider for management and will come off-study.', 'Insulin resistance will be measured using the homeostatic method assessment for', 'insulin resistance (HOMA-IR; fasting insulin (microU/L) X FPG (nmol/L)/22.5) and', 'IGFBP-1 (a measure of insulin sensitivity strongly correlated with euglycemic', 'insulin clamp testing). 29 Measures for an individual participant at weeks 12 and 24', 'will be compared to baseline.', \"St. Jude Children's Research Hospital\", 'Initial version, dated: 04-10-20', 'IRB approkB date 00-00-00', 'NUMBER: 20-0550', 'Protocol document date: 10-12-2020', 'IRB APPROVAL DATE: 11/10/2020']['PREDM', 'Page 22', '4.2.3 Exploratory Outcomes of PREDM', 'Diabetes development over time', 'Although we anticipate few, if any, survivors will develop diabetes during the 24-', 'week trial period, we would like to follow over time. In order to do so, we will', 'monitor PREDM participants at any SJLIFE core assessment or other return visit', 'that includes a measurement of weight and fasting blood work (FPG and HbA1c)', 'for development of diabetes. SJLIFE core assessments typically occur every 3-5', 'years, however some participants return for specific studies sooner. We', 'acknowledge that this will not capture all events in real time as some survivors may', 'not seek medical care regularly and diabetes may remain undiagnosed.', 'Anthropometrics', 'Weight', 'BMI', 'Body fat % by skin calipers will be calculated from assessment of skinfold fat', 'using the 3-site method from Jackson-Pollack for men41 (measured at chest,', 'abdomen and thigh) and women42 (measured at triceps, suprailiac and thigh).', 'This method has been found to be highly correlated with body fat percentage by', 'dual-energy x-ray absorptiometry in childhood cancer survivors. 43', 'Abdominal circumference (cm): measured at the midpoint between the lowest rib', 'and the upper border of the iliac crest', 'Hip circumference (cm): measured at the level of the pubic symphysis and the', 'greatest gluteal protuberance', 'Waist-to-Hip Ratio', 'Physical activity and frailty measures', 'Self-reported physical activity reported using National Health and Nutrition', 'Survey Physical Activity Questionnaire, 44 administered as part of SJLIFE', 'Core', 'assessment on Day 0 (baseline) and then at study visits on week 12 and 24.', 'Change from baseline for an individual participant will be assessed.', 'Physical activity: Physical activity will be monitored by accelerometer using an', 'Actigraphy which will be sent to participants following screening assessments', 'before starting study drug and prior to, week 12 and 24 campus visits. The', 'accelerometer will collect 7 consecutive days of physical activity data while the', 'participant is in their home/routine setting. They will receive an accelerometer', 'with written instructions, programmed to begin recording 12:01 a.m. We have', 'successfully used this method to collect physical activity data on over 2000', 'members of the SJLIFE cohort in other studies (R01CA174851; R01CA132901)', 'many participants will be familiar with this data collection strategy. Wearing', \"St. Jude Children's Research Hospital\", 'Initial version, dated: 04-10-20', 'IRB approkB date 00-00-00', 'NUMBER: 20-0550', 'Protocol document date: 10-12-2020', 'IRB APPROVAL DATE: 11/10/2020']\n\n###\n\n", "completion": "END"}